+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


US Electroceuticals Market 2019-2025

  • ID: 4987995
  • Report
  • January 2020
  • Region: United States
  • Orion Market Research Private Limited


  • Abbott Laboratories Inc.
  • Boston Scientific Corp.
  • Cochlear Ltd.
  • Electrocore Inc.
  • GlaxoSmithKline PLC
  • Sonova Holding AG
The US contributes significantly to the growth of the electroceuticals market. The market growth is attributed to the rise in the prevalence of arrhythmia, a growing number of neural disorders, and a high prevalence of hearing loss. In addition, the rising number of Parkinson’s disease and expected approvals for retinal implants in the US are anticipated to contribute significantly to the growth of the electroceuticals market. The US has a high incidence and prevalence rate of heart diseases due to the sedentary lifestyle, excessive consumption of alcohol, consumption of junk food, and a high number of diabetic and obese patients.

Traumatic brain injury is the most common cause of fatality and disability in the US. As per the report of the Centers for Disease Control and Prevention (CDC), in 2017, 30% of all the injury-related mortalities occurred due to the traumatic brain injury in the US. According to the Center for Medicare and Medicaid Services, in 2017, the US national healthcare expenditure was around $3.5 trillion showing a 3.9% increase in healthcare expenditure. The US has the highest healthcare spending across the globe. In the US, the per capita healthcare expenditure per person in 2017 was around $10,739, as per the CMS.

The growing startups such as Cala Health Incorporated, Axonics Modulation Technologies Incorporated, and others in this market are contributing to the growth of the electroceuticals market in the US. Moreover, the presence of major market players in the US is projected to make a significant contribution to the growth of electroceuticals market in the region. Abbott Laboratories Incorporated, Advanced Bionics AG, BioElectronics Corporation, Biotronik Incorporated, Cochlear Corporation, and other electroceuticals market players provide hearing aids, pacemakers, defibrillators, SCS, and other devices. These companies are constantly focusing on making advancements in their product offerings to offer superior quality products. For instance, Biotronik Incorporated had launched the PlexaProMRI S DX lead, with DF4/IS-1 connector.

Research Methodology

The market study of the US electroceuticals market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. The US Electroceuticals Market Research and Analysis by Product
2. The US Electroceuticals Market Research and Analysis by End-users

The Report Covers
  • Comprehensive research methodology of the US electroceuticals market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the US electroceuticals market.
  • Insights about market determinants which are stimulating the US electroceuticals market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown


  • Abbott Laboratories Inc.
  • Boston Scientific Corp.
  • Cochlear Ltd.
  • Electrocore Inc.
  • GlaxoSmithKline PLC
  • Sonova Holding AG
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. USElectroceuticals Market by Product and its Application
5.1.1. Cardioverter Defibrillators and Cardiac Pacemaker Arrhythmias
5.1.2. Deep Brain Stimulators Parkinson’s Disease Depression
5.1.3. Spinal Cord Stimulators Failed Back Syndrome Ischemia
5.1.4. Vagus Nerve Stimulators Epilepsy
5.1.5. Cochlear Implants Sensorineural Hearing Loss
5.1.6. Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators) Urinary Incontinence Treatment-Resistant Depression
5.2. USElectroceuticals Market by End-Users
5.2.1. Hospitals and Clinics
5.2.2. Research Institutes

6. Company Profiles
6.1. Abbott Laboratories Inc.
6.2. Advanced Bionics AG
6.3. Boston Scientific Corp.
6.4. Cigna Corp.
6.5. Cochlear Ltd.
6.6. Demant A/S
6.7. Edwards Lifesciences Corp.
6.8. Electrocore Inc.
6.9. Functional Neuromodulation Ltd.
6.10. Getinge AB
6.11. GlaxoSmithKline PLC
6.12. Medtronic PLC
6.13. Sonova Holding AG
6.14. ZOLL Medical Corp.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories Inc.
  • Advanced Bionics AG
  • Boston Scientific Corp.
  • Cigna Corp.
  • Cochlear Ltd.
  • Demant A/S
  • Edwards Lifesciences Corp.
  • Electrocore Inc.
  • Functional Neuromodulation Ltd.
  • Getinge AB
  • GlaxoSmithKline PLC
  • Medtronic PLC
  • Sonova Holding AG
  • ZOLL Medical Corp.
Note: Product cover images may vary from those shown